Selective cyclooxygenase-2 inhibition produces heterogeneous erythema response to ultraviolet irradiation.
Rodriguez-Burford
Cristina
C
Tu
John H
JH
Mercurio
Marygail
M
Carey
Delicia
D
Han
Rujing
R
Gordon
Gary
G
Niwas
Santosh
S
Bell
Walter
W
Elmets
Craig A
CA
Grizzle
William
W
Pentland
Alice P
AP
D000068579:Celecoxib; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004890:Erythema / Q000532:radiotherapy*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D008565:Membrane Proteins; D018809:Proliferating Cell Nuclear Antigen; D011720:Pyrazoles; D013449:Sulfonamides; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D000068579:Celecoxib